These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6265685)

  • 1. Cyproheptadine in the control of Cushing's disease.
    Hsu TH; Gann DS; Tsan KW; Russell RP
    Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
    Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
    Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report.
    Zgliczyński S; Kozłowicz I; Wilczyńska J; Baranowska B
    Mater Med Pol; 1980; 12(1-2):85-90. PubMed ID: 6276625
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR; Nowakowski KJ; Jackson IM
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of cyproheptadine in the treatment of Cushing's disease].
    Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
    Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
    [No Abstract]   [Full Text] [Related]  

  • 6. Dynamics of adrenocorticotropin (ACTH) secretion in cyclic Cushing's syndrome: evidence for more than one abnormal ACTH biorhythm.
    Jordan RM; Ramos-Gabatin A; Kendall JW; Gaudette D; Walls RC
    J Clin Endocrinol Metab; 1982 Sep; 55(3):531-7. PubMed ID: 6284783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W; Vetter H; Beckerhoff R; Würsten D; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1320-2. PubMed ID: 1034340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the antiserotonin drug, cyproheptadine, on plasma beta-endorphin and beta-lipotropin in patients with Itsenko-Cushing's disease.
    Slavnov VN; Valueva GV; Luchitsky EV
    Exp Clin Endocrinol; 1985 Jun; 85(3):341-50. PubMed ID: 2995088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine-induced remission of Cushing's disease.
    Krieger DT; Amorosa L; Linick F
    N Engl J Med; 1975 Oct; 293(18):893-6. PubMed ID: 1177986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
    Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
    Whitehead HM; Beacom R; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):193-201. PubMed ID: 2161298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defect in ACTH control after hypophysectomy in Cushing's disease.
    N Engl J Med; 1982 Mar; 306(11):679-80. PubMed ID: 6276745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamics of beta-lipotropin and beta-endorphin levels in Itsenko-Cushing disease patients being treated with the antiserotonin preparation cyproheptadine (peritol) and chloditan].
    Slavnov VN; Valueva GV; Luchitskiĭ EV
    Ter Arkh; 1984; 56(9):119-22. PubMed ID: 6096979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on cyproheptadine in Cushing's disease.
    N Engl J Med; 1977 Mar; 296(10):576-7. PubMed ID: 189191
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of cyproheptadine (peritol) as a drug blocking corticotropin secretion in the treatment of Itsenko-Cushing's disease.
    Komissarenko IV; Cheban AK; Rybakov SI; Pomerantsev YuV ; Slavnov VI; Luchitskii EV
    Neurosci Behav Physiol; 1982; 12(6):494-6. PubMed ID: 6314174
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma.
    Jimenez-Alonso J; Munoz-Avila J; Jaimez L; Pérez-Jimenez F; Bellido C; Jiménez-Perepérez JA
    Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor.
    Leveston SA; McKeel DW; Buckley PJ; Deschryver K; Greider MH; Jaffe BM; Daughaday WH
    J Clin Endocrinol Metab; 1981 Oct; 53(4):682-9. PubMed ID: 6270170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC; Twum-Barima Y
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.